Just one monthly SUTOL dose. No daily pills, no painful injections.
SUTOL's monthly oral platform delivers consistent therapy for long-term conditions, offering patients freedom from daily medication burdens.
While daily oral medications are simple, they require consistent adherence that's challenging for many patients managing chronic conditions.
Current long-acting injectables are effective but require clinic visits, painful injections, and cannot be retrieved once injected.
A safe, patient-friendly, cost-effective, pharmacy-based oral solution that ensures adherence without the burdens of injections.
Originating from the laboratories of Professors Langer and Traverso at MIT with 6 years of translational research, SUTOL Bio combines decades of pioneering research in drug delivery with cutting-edge biomedical engineering to create transformative therapies for patients worldwide.
We're advancing the future of drug delivery. Connect with us to explore partnership opportunities.
Contact Our Team